TEGSEDI 284mg solution for injection in pre-filled syringe AKCEA THERAPEUTICS I ORIGINAL MEDICINE
Chemical substance: inotersen
ATC code: N07XX15 • Nervous system | Other nervous system drugs | Other nervous system drugs
Active substance
Results for the substance inotersen
1 result
About this active substance
Inotersen is a medication used for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR), a rare genetic condition. It works by inhibiting the production of transthyretin, reducing amyloid accumulation in tissues and alleviating disease symptoms.
The medication is administered as a subcutaneous injection, as directed by a doctor, usually once weekly. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the response to therapy.
Patients should be aware of potential side effects, such as injection site reactions, nausea, or headaches. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, nausea, and headaches. In rare cases, severe reactions such as allergic reactions or liver failure may occur. Patients should be informed of these risks before administration.
The medication is administered as a subcutaneous injection, as directed by a doctor, usually once weekly. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the response to therapy.
Patients should be aware of potential side effects, such as injection site reactions, nausea, or headaches. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, nausea, and headaches. In rare cases, severe reactions such as allergic reactions or liver failure may occur. Patients should be informed of these risks before administration.